Hilzinger Kurt J's Form 4 filing
Outlook Therapeutics, Inc. (OTLK) · filed Oct 5, 2022
- Accession no.
- 0001209191-22-052778
- Filed
- Oct 5, 2022
- Trade date
- Oct 4-5, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $142.5K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hilzinger Kurt JCIK 0001191504 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 4, 2022 | Common Stock | PPurchaseAcquired | +95,541 | $1.29 | +$123,247.89 | 457,455 | Direct | |
| Oct 5, 2022 | Common Stock | PPurchaseAcquired | +15,662 | $1.23 | +$19,264.26 | 473,117 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.